India  

Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021

IndiaTimes Monday, 4 January 2021
The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday. "We have four facilities coming up and we are planning (to make) around 200 million doses in Hyderabad, 500 million doses in other cities," the company's MD Krishna Ella said. The company has 20 million doses available so far, he added.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Bharat Biotech aiming to achieve 700 million doses capacity in 4 facilities: MD Ella

Bharat Biotech aiming to achieve 700 million doses capacity in 4 facilities: MD Ella 01:18

While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna M Ella said, "Currently, we have 20 million doses. We are aiming to achieve 700 million doses capacity in four facilities-...

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Can person with any allergy take COVID-19 shots? Know what experts say

Bharat Biotech, the manufacturer of the COVID-19 vaccine said that those who have known allergies to any component of Covaxin should not take the jab.
DNA

Ocugen to seek emergency nod for Covaxin from Health Canada

Bharat Biotech’s US partner Ocugen said it will be seeking an emergency use nod for India’s first indigenously developed Covid-19 vaccine Covaxin from the..
IndiaTimes

Ocugen to seek full approval for Covaxin in US via BLA instead of EUA

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be..
IndiaTimes

Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be..
IndiaTimes

Covaxin Covaxin Vaccine against COVID-19

Experts question Covaxin’s high private market price as R&D was govt subsidised

Experts have questioned the rationale of high prices of Covaxin since it is based on an established technology, is domestically-produced, and it’s R&D has been..
IndiaTimes

Hyderabad Hyderabad Capital of Telangana, India

Hyderabad IYC workers throw bike in lake as a protest against rising fuel price |Watch|Oneindia News [Video]

Hyderabad IYC workers throw bike in lake as a protest against rising fuel price |Watch|Oneindia News

On Friday, a video has surfaced, in which a few members from the Telangana Youth Congress are seen throwing a bike into a lake. The video of them dumping the two-wheeler into the Hussain Sagar Lake in Hyderabad has gone viral. #IYC #Hyderabad #ViralVideo

Credit: Oneindia    Duration: 01:20Published
Monoclonal antibodies control Covid symptoms in 24 hours, says AIG chairman Dr Reddy | Oneindia News [Video]

Monoclonal antibodies control Covid symptoms in 24 hours, says AIG chairman Dr Reddy | Oneindia News

Around 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad-based Asian Institute of Gastroenterology. Chairperson of the hospital, Dr Nageshwar Reddy said that in just 24 hours the patients recovered from clinical symptoms like fever, body ache etc. #MonoclonalAntibodies #SingleDoseDrug #Covid19

Credit: Oneindia    Duration: 01:40Published
IMA holds passing out parade | Gentleman Cadets of Cadet Training Wing Hyderabad | Oneindia News [Video]

IMA holds passing out parade | Gentleman Cadets of Cadet Training Wing Hyderabad | Oneindia News

Passing out parade of 28 Gentleman Cadets of Cadet Training Wing was held in Hyderabad today. The cadets completed their training at the Military College of Electronics and Mechanical Engineering. The Cadets who were piped as commissioned officers in the rank of Lieutenant by senior military officers were welcomed into the fraternity of the officer cadre of the Indian Army.

Credit: Oneindia    Duration: 02:21Published

Covishield produces more antibodies than Covaxin, finds study

Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by..
IndiaTimes
Central Government signs deal for 30 crore Covid jabs with Hyderabad's Biological-E | Oneindia News [Video]

Central Government signs deal for 30 crore Covid jabs with Hyderabad's Biological-E | Oneindia News

The central government said it had signed a deal with Hyderabad-based biotechnology and biopharmaceutical company Biological-E for 30 crore doses of the Covid-19 vaccine. It is still in clinical trials #CentralGovernment #BiologicalE #CovidVaccine

Credit: Oneindia    Duration: 01:15Published

You Might Like


Related videos from verified sources

Why It’s Hard to Make Vaccines: Explained [Video]

Why It’s Hard to Make Vaccines: Explained

Why It’s Hard to Make Vaccines: Explained. With the high demand for the COVID-19 vaccine, its rollout has undergone massive delays around the globe. Here are some reasons why vaccine..

Credit: Wibbitz Top Stories     Duration: 01:09Published
Over 55 lakh doses of vaccines gifted to neighbours: MEA [Video]

Over 55 lakh doses of vaccines gifted to neighbours: MEA

During a press briefing on January 28, MEA spokesperson Anurag Srivastava informed that over 55 lakh doses of vaccines have been gifted neighbours and extended neighbourhood since January 20. MEA..

Credit: ANI     Duration: 01:35Published
Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka [Video]

Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka

India once again established its position as a reliable partner in Covid-19 assistance. It dispatched Covishield to Bahrain and Sri Lanka under the Vaccine Maitri Initiative. Sri Lanka to receive a..

Credit: HT Digital Content     Duration: 01:29Published

Related news from verified sources

Covaxin generated excellent safety data, says Bharat Biotech

Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat...
Mid-Day Also reported by •IndiaTimes

Bharat Biotech gets permission to manufacture Covaxin for sale

The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the...
Mid-Day Also reported by •IndiaTimesHinduDNA

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being...
IndiaTimes